Christoph KroenerHead of IVAC Mutanome Lead Structure at BioNTech AG
Since April 2016, Christoph Kröner works as Head of IVAC Mutanome Lead Structure at BioNTech RNA Pharmaceuticals GmbH with strong focus on developmental work for BioNTech’s individualized cancer treatment programs. He has more than eight years of experience working with nucleic acids. His work focused on mRNA-based therapeutics when he joined BioNTech in 2014 as a scientist. Christoph Kröner holds a diploma and PhD in chemistry from the University of Stuttgart, Germany.